Consensus Forecast

Consensus Forecast

January 2017

Consensus compiled by Vara from forecasts by the 17 analysts listed below.

FY 2016 E

$ High Mean Low
Sales 13'205m 12'823m 12'607m
EBITDA* 2'760m 2'579m 2'309m
Net Income 1'502m 1'211m 1'087m
Earnings per share (EPS)** 17.38 16.08 13.29

FY 2017 E

$ High Mean Low
Sales 14'980m 13'487m 12'622m
EBITDA* 3'146m 2'844m 2'561m
Net Income 1'810m 1'527m 1'303m
Earnings per share (EPS)** 20.72 18.36 14.75

* excluding restructuring and impairment
** EPS on a fully-diluted basis, excluding restructuring and impairment

Target Share Price

CHF High Mean Low

480 441 325

Analysts Covering Syngenta

The following list* includes institutions that publish regular research reports on Syngenta. Their reports have been used to create the consensus forecast included above.

Institution Analyst
AB Bernstein Jeremy Redenius
Baader Helvea Markus Mayer
Citigroup Andrew Benson
Deutsche Bank Virginie Boucher-Ferte
Equita Massimo Bonisoli
Exane BNP Paribas James Knight
Investec Investment Management Paul Satchell
Jefferies Laurence Alexander
Kepler Cheuvreux Christian Faitz
Liberum Capital Sophie Jourdier
Macquarie Cooley May
MainFirst Bank Andreas Heine
Mirabaud Securities Bernd Pomrehn
Morgan Stanley Paul Walsh
Redburn Tony Jones
UBS Patrick Rafaisz
ZKB Zürcher Kantonalbank Philipp Gamper

* The above list is a selection of analysts currently covering Syngenta. We do not make any claim that this list is comprehensive of all institutions publishing regular research reports on Syngenta.


Any opinions, forecasts, estimates, projections or predictions regarding Syngenta's performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Syngenta. By providing these names, Syngenta does not imply its endorsement of or concurrence with their reports, conclusions or recommendations and Syngenta does not assume any liability for the accuracy of the information.

Please note that this list does not constitute a solicitation to buy, hold or sell securities.

Note: To add/edit content, please navigate through the Advanced Editing visible in the ribbon at the top.

Find it here

Expand all